APA (7th ed.) Citation

MAM, A., A, B., FIA, E., FH, B., SSA, A., AA, C., & AG, F. (2026). Control of cardiotoxicity via nasal in-situ pH-sensitive transbilosomal formulation of candesartan. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05601-5

Chicago Style (17th ed.) Citation

MAM, Ali, Belal A, El-Ela FIA, Baali FH, Alghamdi SSA, Chaudhary AA, and Fouad AG. "Control of Cardiotoxicity via Nasal In-situ PH-sensitive Transbilosomal Formulation of Candesartan." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05601-5.

MLA (9th ed.) Citation

MAM, Ali, et al. "Control of Cardiotoxicity via Nasal In-situ PH-sensitive Transbilosomal Formulation of Candesartan." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05601-5.